English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | May 31, 2020

GUARDANT: Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients

Elle Johnson | May 25, 2020

GPS COVID-19 patient tracking burdens fundamental rights

Elle Johnson | May 25, 2020

Disruptive Dozen to revolutionize health care

Press release submission | May 15, 2020

BETTERLIFE PHARMA: Announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon

Carrie Bradon | May 15, 2020

CEO of Iceland genetics company says children with COVID-19 less likely to spread virus to adults

Elle Johnson | May 15, 2020

Societi finds no evidence linking COVID-19 and Kawasaki disease

Michael Pineda | May 6, 2020

States accused of hoarding drug that could help COVID-19 patients

Press release submission | Apr 30, 2020

TELEMIND: Doctors From TeleMind, A Nevada Telepsychiatry Clinic, Are Treating Patients From Home Amid Coronavirus

Trending

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'

+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’

  • « First
  • «
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily